An Open Label, Multi-Center, Non-Interventional Post-Marketing Surveillance to Monitor the Safety and Efficacy of ALTARGO® (Retapamulin) Administered in Korean Patients According to the Prescribing Information

BACKGROUND: With the approval of topical retapamulin ointment in 2011, it was officially required to conduct a post-marketing surveillance (PMS) study to obtain further data of its safety profile and effectiveness, in accordance with the requirement of the Korean Ministry of Food and Drug Safety (MF...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Woosung, Lee, Yil-Seob, Park, Chun-Wook, Yoon, Moon-Soo, Ro, Young Suck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029962/
https://www.ncbi.nlm.nih.gov/pubmed/30065584
http://dx.doi.org/10.5021/ad.2018.30.4.441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029962/
https://www.ncbi.nlm.nih.gov/pubmed/30065584
http://dx.doi.org/10.5021/ad.2018.30.4.441

Ejemplares similares